October 9, 2024 AI for Pipeline Discovery and Beyond By Sarah Dolman AI, Biopharma, Digital Health Read More
June 10, 2024 Beyond drug supply: BIOSECURE and early-stage drug R&D By Sarah Dolman Biopharma Read More
December 21, 2023 Multi-Cancer Early Detection tests – Will they become part of regular clinical care? By Sarah Dolman Diagnostics Read More
February 10, 2023 Is the future of US pharma manufacturing domestic? By Sarah Dolman Biopharma Read More
January 6, 2023 Can BiTEs take a bite out of CAR-Ts in hematologic cancers? By Sarah Dolman Biopharma Read More
December 24, 2021 The road ahead for genomic testing By Sarah Dolman Biopharma, Diagnostics, Medical Devices, Payers Read More
